Inhibition of BRD4 could block agonist-induced pathological hypertrophy in human induced pluripotent stem cell-derived cardiomyocytes, and attenuate TAC-induced myocardial fibrosis in mice (Duan et al., 2017; Song et al., 2019). Here, BRD4 is linked to Myocardial fibrosis.